SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MedImmune -- Ignore unavailable to you. Want to Upgrade?


To: Bosco who wrote (221)6/5/2000 9:45:00 PM
From: bob zagorin  Read Replies (1) | Respond to of 416
 
Salomon Smith Barney's well-respected bio analyst Meirav Chovav strongly recommends 4 top-tier bios: AMGN, DNA, IDEC & MEDI because of their "strong EPS growth potential and well-stocked pipelines". For MEDI, she estimates very strong Synagis sales growth: $405.5m/00; $531m/01; $630m/02. also strong Cytogam growth. She estimates EPS of $3.70 share (pre-split) in 02.